RE:RE:RE:RE:distribution deals next week?Actually it's Cipher who is better off without the deal. On the Activis front they have not even submitted there generic version yet so approval may be a year away not sure why but low market share may and cost must have scared them from launching. Definitely a bonus for Cipher with no competition they should be able to increase market share with the LD version. The analysts had halved revenue in the coming quarters because of the generic version and completion but will probably revise and that means Cipher should enjoy a .10 earnings per quarter until Trulance and later next year Trevyent which could add another .05 cents. All this while cash is piling into the bank. Looking at Bausch for the take out soon.